X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6306) 6306
Publication (2056) 2056
Book Chapter (10) 10
Book Review (10) 10
Conference Proceeding (8) 8
Data Set (6) 6
Book / eBook (3) 3
Magazine Article (2) 2
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (6205) 6205
macaca mulatta (4935) 4935
index medicus (3082) 3082
humans (2630) 2630
virology (2402) 2402
viruses (1644) 1644
immunology (1480) 1480
male (1355) 1355
female (1330) 1330
simian acquired immunodeficiency syndrome - immunology (1278) 1278
simian immunodeficiency virus - immunology (1216) 1216
simian immunodeficiency virus (1027) 1027
virus diseases (1020) 1020
research article (1005) 1005
simian acquired immunodeficiency syndrome - virology (1000) 1000
research (985) 985
monkeys (980) 980
multidisciplinary sciences (948) 948
infectious diseases (939) 939
infection (919) 919
disease models, animal (818) 818
molecular sequence data (812) 812
simian immunodeficiency virus - genetics (793) 793
hiv (792) 792
cell line (768) 768
primates (747) 747
article (746) 746
rhesus macaques (727) 727
medicine (712) 712
health aspects (707) 707
aids (701) 701
viral load (701) 701
infections (661) 661
mice (638) 638
science (617) 617
simian immunodeficiency virus - physiology (612) 612
virus replication (612) 612
vaccines (588) 588
analysis (585) 585
microbiology (563) 563
amino acid sequence (547) 547
cd4-positive t-lymphocytes - immunology (534) 534
physiological aspects (529) 529
monkeys & apes (515) 515
biology (513) 513
proteins (509) 509
macaca mulatta - virology (502) 502
cd8-positive t-lymphocytes - immunology (495) 495
vaccination (493) 493
medicine, research & experimental (490) 490
simian immunodeficiency virus - pathogenicity (477) 477
base sequence (467) 467
neurosciences (461) 461
antibodies, viral - blood (454) 454
simian acquired immunodeficiency syndrome - prevention & control (452) 452
hiv-1 - immunology (441) 441
immunization (434) 434
replication (432) 432
lymphocytes (430) 430
siv (413) 413
macaques (408) 408
hiv-1 infection (406) 406
rhesus-monkeys (406) 406
cells, cultured (398) 398
antibodies (381) 381
time factors (376) 376
t cells (374) 374
neurons (372) 372
expression (370) 370
disease progression (367) 367
human immunodeficiency virus--hiv (367) 367
pathogenesis and immunity (367) 367
hiv infections - immunology (364) 364
macaca mulatta - immunology (362) 362
saids vaccines - immunology (362) 362
vaccine (354) 354
immune-responses (347) 347
aids vaccines - immunology (344) 344
macaque (343) 343
in-vivo (341) 341
hiv-1 - genetics (339) 339
cell biology (333) 333
brain (331) 331
viremia (329) 329
neutralization tests (328) 328
simian acquired immunodeficiency syndrome - pathology (328) 328
animal models (327) 327
studies (327) 327
veterinary sciences (319) 319
gene expression (317) 317
animal diseases (316) 316
human-immunodeficiency-virus (315) 315
hiv-1 (314) 314
dna (311) 311
hiv infections - virology (307) 307
human immunodeficiency virus (303) 303
responses (299) 299
cells (298) 298
genetic aspects (298) 298
immune response (296) 296
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6259) 6259
Chinese (28) 28
Russian (13) 13
German (5) 5
French (2) 2
Italian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 512, Issue 1, pp. 74 - 77
The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear... 
LATENT INFECTION | REPLICATION | INITIATION | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | VACCINE | PREVENTION | DYNAMICS | IMMUNODEFICIENCY VIRUS-INFECTION | DEPENDS | HIV-1 INFECTION | DNA, Viral - biosynthesis | Macaca mulatta - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | RNA, Viral - blood | Rectum - virology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Proviruses - genetics | Time Factors | Treatment Failure | Female | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Virus Replication - drug effects | Anti-Retroviral Agents - therapeutic use | Anti-Retroviral Agents - pharmacology | Viremia - drug therapy | Simian Immunodeficiency Virus - physiology | DNA, Viral - blood | Carrier State - virology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | Viremia - virology | Anti-Retroviral Agents - administration & dosage | Carrier State - drug therapy | Kinetics | Viral Load - drug effects | Simian Immunodeficiency Virus - drug effects | Physiological aspects | Simian immunodeficiency virus | Virulence (Microbiology) | Studies | Antiretroviral drugs | Lymphocytes | Human immunodeficiency virus--HIV | Infections | Monkeys & apes | Deoxyribonucleic acid--DNA
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 514, Issue 7520, pp. 47 - 53
Journal Article
Nature, ISSN 0028-0836, 05/2011, Volume 473, Issue 7348, pp. 523 - 527
The acquired immunodeficiency syndrome (AIDS)-causing lentiviruses human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) effectively evade... 
CHALLENGE | MACAQUE MODEL | REPLICATION | PROTECTION | RHESUS-MONKEYS | PRIMARY HIV-1 INFECTION | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | AIDS | IMMUNODEFICIENCY VIRUS SIVMAC239 | Immunity, Mucosal - immunology | Vaccines, DNA - genetics | Macaca mulatta - blood | AIDS Vaccines - immunology | Macaca mulatta - immunology | Vaccines, DNA - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | Viral Load | CD4-Positive T-Lymphocytes - immunology | Simian Immunodeficiency Virus - isolation & purification | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Time Factors | Immunologic Memory - immunology | Simian Immunodeficiency Virus - immunology | Cytomegalovirus - genetics | Simian Immunodeficiency Virus - pathogenicity | RNA, Viral - analysis | Simian Acquired Immunodeficiency Syndrome - blood | Genetic Vectors - genetics | Simian Acquired Immunodeficiency Syndrome - prevention & control | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Virus Replication | T-Lymphocytes - immunology | CD8-Positive T-Lymphocytes - immunology | Plasma | Immunization | Acquired immune deficiency syndrome--AIDS | Pathogenesis | Human immunodeficiency virus--HIV | Deoxyribonucleic acid--DNA
Journal Article
Journal Article
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7644, pp. 248 - 251
Journal Article
Nature, ISSN 0028-0836, 01/2012, Volume 481, Issue 7381, pp. 371 - 375
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2012, Volume 109, Issue 13, pp. 5034 - 5039
Journal Article
Journal of Virology, ISSN 0022-538X, 06/2008, Volume 82, Issue 11, pp. 5408 - 5416
Journal Article
Nature, ISSN 0028-0836, 11/2012, Volume 491, Issue 7422, pp. 129 - 133
Journal Article
Nature, ISSN 0028-0836, 02/2011, Volume 470, Issue 7335, pp. 543 - 550
Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging... 
MEMORY B-CELLS | YELLOW-FEVER VACCINE | MULTIDISCIPLINARY SCIENCES | DERMAL DENDRITIC CELLS | IN-VIVO | TOLL-LIKE RECEPTORS | GERMINAL CENTER | EXPRESSION | T-CELLS | LANGERHANS CELLS | ANTIGEN | Viral antibodies | Antibodies | Chemical properties | Research | Immunity | Proteins | Nanoparticles | Plasma | Immunology | Avian flu | Immune system
Journal Article
Nature, ISSN 0028-0836, 09/2007, Volume 449, Issue 7158, pp. 101 - 104
Most successful vaccines elicit neutralizing antibodies and this property is a high priority when developing an HIV vaccine(1,2). Indeed, passively... 
CHALLENGE | MEDIATED PROTECTION | IN-VITRO | TRANSMISSION |